[1]. Ringshausen, F.C., et al., Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014. Emerg Infect Dis, 2016. 22(6): p. 1102-5.
[2]. Namkoong, H., et al., Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan. Emerg Infect Dis, 2016. 22(6): p. 1116-7.
[3]. Koh, W.J., Nontuberculous Mycobacteria-Overview. Microbiol Spectr, 2017. 5(1).
[4]. Goslee, S. and E. Wolinsky, Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis, 1976. 113(3): p. 287-92.
[5]. Wolinsky, E. and T.K. Rynearson, Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis, 1968. 97(6): p. 1032-7.
[6]. Brown-Elliott, B.A. and R.J. Wallace, Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev, 2002. 15(4): p. 716-46.
[7]. Henkle, E. and K.L. Winthrop, Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med, 2015. 36(1): p. 91-9.
[8]. Wu, U.I. and S.M. Holland, Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis, 2015. 15(8): p. 968-80.
[9]. Santamaria-Jauregui, J., et al., Meningitis caused by Mycobacterium fortuitum. Am Rev Respir Dis, 1984. 130(1): p. 136-7.
[10]. Smith, M.B., M.C. Boyars and G.L. Woods, Fatal Mycobacterium fortuitum meningitis in a patient with AIDS. Clin Infect Dis, 1996. 23(6): p. 1327-8.
[11]. Midani, S. and M.H. Rathore, Mycobacterium fortuitum infection of ventriculoperitoneal shunt. South Med J, 1999. 92(7): p. 705-7.
[12]. Madaras-Kelly, K.J., T.A. DeMasters and D.L. Stevens, Mycobacterium fortuitum meningitis associated with an epidural catheter: case report and a review of the literature. Pharmacotherapy, 1999. 19(5): p. 661-6.
[13]. Fujikawa, K., et al., [A case of Mycobacterium fortuitum meningitis following surgery for meningioma]. Rinsho Shinkeigaku, 2006. 46(7): p. 480-4.
[14]. Kell, C.A., et al., Chronic meningoencephalomyelitis due to Mycobacterium fortuitum in an immunocompetent patient. J Neurol, 2008. 255(11): p. 1847-9.
[15]. Aliabadi, H. and R.K. Osenbach, Intrathecal Drug Delivery Device Infection and Meningitis due to Mycobacterium Fortuitum: A Case Report. Neuromodulation, 2008. 11(4): p. 311-4.
[16]. Xess, A.B., et al., Mycobacterium fortuitum as a cause of acute CNS infection in an immune-competent girl undergoing repeated VP shunt surgeries. BMJ Case Rep, 2019. 12(4).
[17]. Zakrzewski, J., et al., Mycobacterium fortuitum Meningitis: Approach to Lumboperitoneal Shunt Infection. South Med J, 2019. 112(4): p. 217-221.
[18]. Nontuberculous mycobacterial meningitis report of two cases and review.
[19]. Thwaites, G.E., R. van Toorn and J. Schoeman, Tuberculous meningitis: more questions, still too few answers. Lancet Neurol, 2013. 12(10): p. 999-1010.
[20]. Marx, G.E. and E.D. Chan, Tuberculous Meningitis: Diagnosis and Treatment Overview. Tuberculosis Research and Treatment, 2011. 2011: p. 1-9.
[21]. Torok, M.E., Tuberculous meningitis: advances in diagnosis and treatment. British Medical Bulletin, 2015. 113(1): p. 117-131.
[22]. Thwaites, G.E., et al., Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet, 2002. 360(9342): p. 1287-92.
[23]. Yu, J., et al., Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis. The International Journal of Tuberculosis and Lung Disease, 2016. 20(4): p. 494-499.
[24]. Park, K., et al., Diagnostic usefulness of T-cell based assays for tuberculous meningitis in HIV-uninfected patients. Journal of Infection, 2016. 72(4): p. 486-497.
[25]. Kasperbauer, S.H. and M.A. De Groote, The Treatment of Rapidly Growing Mycobacterial Infections. Clinics in Chest Medicine, 2015. 36(1): p. 67-78.
[26]. Griffith, D.E., et al., An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine, 2007. 175(4): p. 367-416.